Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.58 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.58 |
| ▸ | LMNA | P02545 | 1/20 | 0.58 |
| ▸ | DGKA | P23743 | 1/20 | 0.51 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.49 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.49 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.46 |
| ▸ | PPARG | P37231 | 7/20 | 0.46 |
| ▸ | PPARD | Q03181 | 7/20 | 0.46 |
| ▸ | PPARA | Q07869 | 7/20 | 0.46 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.46 |
| ▸ | TSHR | P16473 | 4/20 | 0.46 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | TLR2 | O60603 | 2/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
| ▸ | FABP4 | P15090 | 2/20 | 0.46 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Adipic Acid SCHEMBL2338266 | 0.92 | MEN1 (0.52) | MEN1KMT2AKDM4EDUSP3LMNA | |
| SCHEMBL28712011 | 0.92 | MEN1 (0.59) | MEN1KMT2AKDM4EDUSP3LMNA | |
| SCHEMBL4966666 | 0.92 | MEN1 (0.59) | MEN1KMT2AKDM4EDUSP3LMNA | |
| Adipic Acid SCHEMBL2192313 | 0.91 | KDM4E (0.62) | MEN1KMT2AKDM4EDUSP3LMNA | |
| SCHEMBL6836331 | 0.86 | FFAR1 (0.66) | KMT2ADUSP3LMNADGKAFFAR4 | |
| SCHEMBL28830667 | 0.86 | KDM4E (0.56) | MEN1KMT2AKDM4EDUSP3LMNA | |
| SCHEMBL7574622 | 0.84 | DGKA (0.65) | MEN1KMT2AKDM4EDUSP3LMNA | |
| Dodecanoate SCHEMBL27989755 | 0.83 | MEN1 (0.69) | MEN1KMT2AKDM4EDUSP3LMNA | |
| Dodecanoate SCHEMBL28287632 | 0.83 | MEN1 (0.69) | MEN1KMT2AKDM4EDUSP3LMNA | |
| Octanoic Acid SCHEMBL9928775 | 0.83 | MEN1 (0.69) | MEN1KMT2AKDM4EDUSP3LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024134493-A1 | DRUG DELIVERY SYSTEM FOR TIRZEPATIDE | QUISITIVE THERAPEUTICS (IN) | 2024-06-27 | — | — | WO | disclosed |
| US-11173210-B2 | Temperature-responsive degradable hydrogels | SONORAN BIOSCIENCES, INC. (US) | 2021-11-16 | — | — | US | disclosed |
| US-20210252156-A1 | METHODS OF TREATING NAUSEA UTILIZING SEMI-SOLID DELIVERY VEHICLE COMPOSITIONS COMPRISING GRANISETRON | HERON THERAPEUTICS INC (US) | 2021-08-19 | — | — | US | disclosed |
| EP-3834817-A1 | SEMI-SOLID DELIVERY VEHICLE AND PHARMACEUTICAL COMPOSITIONS | Heron Therapeutics, Inc. (US) | 2021-06-16 | — | — | EP | disclosed |
| US-20200405866-A1 | METHODS OF TREATING NAUSEA UTILIZING SEMI-SOLID DELIVERY VEHICLE COMPOSITIONS COMPRISING GRANISETRON | HERON THERAPEUTICS, INC. | 2020-12-31 | — | — | US | disclosed |
| US-20200323987-A1 | TEMPERATURE-RESPONSIVE DEGRADABLE HYDROGELS | SONORAN BIOSCIENCES, INC. (US) | 2020-10-15 | — | — | US | disclosed |
| EP-3700589-A1 | TEMPERATURE-RESPONSIVE DEGRADABLE HYDROGELS | Sonoran Biosciences, Inc. (US) | 2020-09-02 | — | — | EP | disclosed |
| EP-3424492-B1 | SEMI-SOLID DELIVERY VECHICLE AND PHARMACEUTICAL COMPOSITIONS | HERON THERAPEUTICS INC (US) | 2020-05-27 | — | — | EP | disclosed |
| US-10357570-B2 | Methods of treating nausea utilizing semi-solid delivery vehicle compositions comprising granisetron | HERON THERAPEUTICS, INC. (US) | 2019-07-23 | — | — | US | disclosed |
| EP-3424492-A1 | SEMI-SOLID DELIVERY VECHICLE AND PHARMACEUTICAL COMPOSITIONS | Heron Therapeutics, Inc. (US) | 2019-01-09 | — | — | EP | disclosed |
| EP-1280558-B1 | SEMI-SOLID DELIVERY VEHICLE AND PHARMACEUTICAL COMPOSITIONS | AP PHARMA INC (US) | 2005-12-07 | — | — | EP | disclosed |
| US-6861068-B2 | Pharmaceutical compositions using semi-solid delivery vehicle | A.P. PHARMA, INC. (US) | 2005-03-01 | — | — | US | disclosed |
| US-20050042194-A1 | A polyorthoester and an excipient carrying antiemetic agents and anesthetics; topical or injectable forms; post operative or chemotherapy-induced emesis | A.P. PHARMA, INC. (US) | 2005-02-24 | — | — | US | disclosed |
| US-6790458-B2 | MIXTURE OF POLYORTHOESTER AND EXCIPIENTS; SUSTAINED RELEASE | AP PHARMA INC. | 2004-09-14 | — | — | US | disclosed |
| US-20040156907-A1 | Pharmaceutical compositions using semi-solid delivery vehicle | HERON THERAPEUTICS, INC. (F/K/A A.P. PHARMA, INC.) | 2004-08-12 | — | — | US | disclosed |
| US-20030212148-A1 | Pharmaceutical compositions using semi-solid delivery vehicle | AP PHARMA, INC. | 2003-11-13 | — | — | US | disclosed |
| US-6613355-B2 | Suitable for local delivery of the active agent, time-release agents | A.P. PHARMA, INC. | 2003-09-02 | — | — | US | disclosed |
| EP-1280558-A2 | SEMI-SOLID DELIVERY VEHICLE AND PHARMACEUTICAL COMPOSITIONS | Advanced Polymer Systems, Inc. (US) | 2003-02-05 | — | — | EP | disclosed |
| US-20020037300-A1 | Semi-solid delivery vehicle and pharmaceutical compositions | HERON THERAPEUTICS, INC. (F/K/A A.P. PHARMA, INC.) | 2002-03-28 | — | — | US | disclosed |
| WO-2001085139-A2 | SEMI-SOLID DELIVERY VEHICLE AND PHARMACEUTICAL COMPOSITIONS | ADVANCED POLYMER SYSTEMS, INC. (US) | 2001-11-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020037300-A1 | Semi-solid delivery vehicle and pharmaceutical compositions | LIPA, CEL, SORD | MEN1 3661/4885KMT2A 3457/4885KDM4E 1899/4885 |
| US-20030212148-A1 | Pharmaceutical compositions using semi-solid delivery vehicle | CEL, LIPA, SORD | MEN1 3464/4885KMT2A 3736/4885KDM4E 2143/4885 |
| US-20200323987-A1 | TEMPERATURE-RESPONSIVE DEGRADABLE HYDROGELS | LCT, DLST, ALG1 | MEN1 1203/4885KMT2A 4008/4885KDM4E 3690/4885 |
| US-20200405866-A1 | METHODS OF TREATING NAUSEA UTILIZING SEMI-SOLID DELIVERY VEHICLE COMPOSITIONS COMPRISING GRANISETRON | LPXN, CRH, NTSR1 | MEN1 1883/4885KMT2A 2578/4885KDM4E 2463/4885 |
| US-20210252156-A1 | METHODS OF TREATING NAUSEA UTILIZING SEMI-SOLID DELIVERY VEHICLE COMPOSITIONS COMPRISING GRANISETRON | LPXN, CRH, NTSR1 | MEN1 1883/4885KMT2A 2578/4885KDM4E 2463/4885 |
| US-10357570-B2 | Methods of treating nausea utilizing semi-solid delivery vehicle compositions comprising granisetron | LPXN, CRH, NTSR1 | MEN1 1883/4885KMT2A 2578/4885KDM4E 2463/4885 |
| US-20040156907-A1 | Pharmaceutical compositions using semi-solid delivery vehicle | CEL, LIPA, SORD | MEN1 3464/4885KMT2A 3736/4885KDM4E 2143/4885 |
| US-11173210-B2 | Temperature-responsive degradable hydrogels | LCT, DLST, ALG1 | MEN1 1203/4885KMT2A 4008/4885KDM4E 3690/4885 |
| US-20050042194-A1 | A polyorthoester and an excipient carrying antiemetic agents and anesthetics; topical or injectable forms; post operative or chemotherapy-induced emesis | PUF60, FAU, STOM | MEN1 2664/4885KMT2A 3446/4885KDM4E 3469/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.